Protein (4)
オンライン (4)
Human (3)Rhesus macaque (1)
His Tag & Strep Tag (2)- (2)
Unconjugated (3)Biotin-labeled (1)
| 製品番号 | 種 | 発現システム | 製品説明 | タンパク質の構造 | 純度 | 特性 |
|---|---|---|---|---|---|---|
CL4-H52P5 | HEK293 | Human Claudin-4 Full Length Protein (VLP) | ||||
CL4-H5587 | InsectCells | Human Claudin-4 Protein, His,Twin-Strep Tag (Detergent) | ![]() | |||
CL4-H85D3 | InsectCells | Biotinylated Human Claudin-4 Full Length Protein, Avitag™,His&Flag Tag (Detergent) | ![]() | |||
CL4-R5583 | InsectCells | Rhesus macaque Claudin-4 Protein, His,Twin-Strep Tag (Detergent) | ![]() |
| 英語名 | 研究コード | 研究開発ステージ | 会社 | 適応症 | 臨床試験 |
|---|---|---|---|---|---|
| Cobolimab | WBP 296A; TSR-022; GSK-4069889 | Phase 3 Clinical | Anaptysbio Inc | Liver Neoplasms; Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms | 詳細 |
| Sabatolimab | MBG-453; NVP-MBG453 | Phase 3 Clinical | Novartis Pharma Ag | Leukemia, Myelogenous, Chronic; Leukemia; Preleukemia; Hematologic Diseases; Leukemia, Myeloid; Polycythemia Vera; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Glioblastoma; Neoplasms; Primary Myelofibrosis; Bone Marrow Diseases; Leukemia, Myeloid, Acute; Thrombocythemia, Essential | 詳細 |
| Surzebiclimab | BGB-A425 | Phase 2 Clinical | Head and Neck Neoplasms; Squamous Cell Carcinoma of Head and Neck | 詳細 | |
| Lomvastomig | RG-7769; RO-7121661 | Phase 2 Clinical | F. Hoffmann-La Roche Ltd | Solid tumours; Neoplasms; Small Cell Lung Carcinoma; Esophageal Squamous Cell Carcinoma; Carcinoma, Non-Small-Cell Lung; Melanoma | 詳細 |
| BMS-986258 | ONO-7807; BMS-986258 | Phase 2 Clinical | Five Prime Therapeutics Inc, Bristol-Myers Squibb Company | Neoplasms | 詳細 |
| Sabestomig | AZD-7789 | Phase 2 Clinical | AstraZeneca Ag | Solid tumours; Esophageal Neoplasms; Stomach Neoplasms; Hodgkin Disease; Digestive System Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Gastrointestinal Neoplasms | 詳細 |
| S-095018 | S095018; S-095018 | Phase 2 Clinical | Servier Bio-Innovation LLC, Institut De Recherches Internationales Servier | Carcinoma, Non-Small-Cell Lung | 詳細 |
| Anti Tim-3/CD123 CAR-T Cell Therapy(Xuzhou Medical University) | Phase 2 Clinical | Xuzhou Medical University (Xzmu), The Affiliated Hospital Of Xuzhou Medical University | Leukemia, Myeloid, Acute | 詳細 | |
| TB-006 | TB-006; TB006 | Phase 2 Clinical | TrueBinding Inc | Autism Spectrum Disorder; Coronavirus Disease 2019 (COVID-19); Alzheimer Disease | 詳細 |
| Verzistobart | INCAGN-02390; INCAGN-2390 | Phase 2 Clinical | Incyte Corp, Agenus Inc | Triple Negative Breast Neoplasms; Uterine Cervical Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Melanoma; Lymphoma, Follicular; Uveal melanoma; Mesothelioma; Microsatellite instability-high cancer; Small Cell Lung Carcinoma; Lymphoma, Large B-Cell, Diffuse; Ovarian Neoplasms; Carcinoma, Transitional Cell; Mismatch Repair Deficient Cancer; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Carcinoma, Merkel Cell; Stomach Neoplasms; Esophageal Neoplasms; Lymphoma, B-Cell; Head and Neck Neoplasms | 詳細 |
| BC-3402 | BC-3402 | Phase 2 Clinical | Solid tumours; Hematologic Diseases; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Carcinoma, Hepatocellular | 詳細 | |
| TQB-2618(Jiangsu Chia Tai-Tianqing Pharmaceutical) | TQB-2618 | Phase 2 Clinical | Solid tumours; Squamous Cell Carcinoma of Head and Neck; Myelodysplastic Syndromes; Nasopharyngeal Carcinoma; Colorectal Neoplasms; Leukemia, Myeloid, Acute; Esophageal Squamous Cell Carcinoma; Carcinoma, Squamous Cell; Lymphoma; Carcinoma, Hepatocellular; Melanoma | 詳細 | |
| SHR-1702 | SHR-1702 | Phase 1 Clinical | Solid tumours; Myelodysplastic Syndromes; Leukemia, Myeloid, Acute | 詳細 | |
| LY-3321367 | LY-3321367 | Phase 1 Clinical | Eli Lilly And Company | Solid tumours | 詳細 |
| KL-A293 | KL-A293 | Phase 1 Clinical | Anyuan Pharmaceutical Technology (Shanghai) Co Ltd, Sichuan Kelun-Biotech Biopharmaceutical Co Ltd | Neoplasms | 詳細 |
| NB-002 (Suzhou Luosheng Bio-Pharmaceutical) | NB-002 (Suzhou Luosheng Bio-Pharmaceutical); NB-002 (逻晟生物); NB-002 | Phase 1 Clinical | Solid tumours; Neoplasms | 詳細 | |
| LPX-TI641 | LPX-TI-641 | Phase 1 Clinical | LAPIX Therapeutics Inc | Autoimmune Diseases; Multiple Sclerosis; Neuromyelitis Optica; Demyelinating Diseases | 詳細 |
| LB-1410 | LB-1410 | Phase 1 Clinical | L&L Biopharma Co Ltd | Solid tumours; Neoplasms; Lymphoma | 詳細 |
| Anti-PD1/anti-TIM3 bispecific antibody (L&L vision biopharmaceuticals) | Bis-5 | Phase 1 Clinical | L&L Biopharma Co Ltd | Solid tumours; Neoplasms | 詳細 |
| LBL-003 | LBL-003 | Phase 1 Clinical | Solid tumours; Neoplasms | 詳細 | |
| Sym-023 | Sym-023; Sym023; S95018 | Phase 1 Clinical | Symphogen A/S | Solid tumours; Lymphoma; Neoplasm Metastasis | 詳細 |
| WBP-3425 | WBP-3425 | Phase 1 Clinical | Solid tumours; Colonic Neoplasms | 詳細 |

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)
メールアドレス
order.jp@acrobiosystems.com
アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8






